AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 64 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,700,730 | +786.2% | 515,099 | +388.4% | 0.00% | – |
| Q3 2022 | $869,000 | +187.7% | 105,475 | +129.1% | 0.00% | – |
| Q2 2022 | $302,000 | +22.8% | 46,043 | +4.3% | 0.00% | – |
| Q1 2022 | $246,000 | +62.9% | 44,140 | +37.6% | 0.00% | – |
| Q4 2021 | $151,000 | -66.1% | 32,088 | -55.4% | 0.00% | – |
| Q3 2021 | $445,000 | -6.1% | 71,916 | +0.1% | 0.00% | – |
| Q2 2021 | $474,000 | -56.2% | 71,855 | -51.5% | 0.00% | – |
| Q1 2021 | $1,083,000 | +825.6% | 148,032 | +630.4% | 0.00% | – |
| Q4 2020 | $117,000 | +11.4% | 20,266 | +15.0% | 0.00% | – |
| Q3 2020 | $105,000 | -91.7% | 17,619 | -92.8% | 0.00% | – |
| Q2 2020 | $1,259,000 | +2827.9% | 244,411 | +1935.4% | 0.00% | – |
| Q1 2020 | $43,000 | – | 12,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $23,481,000 | 0.99% |
| Cormorant Asset Management, LP | 1,000,000 | $5,940,000 | 0.23% |
| WealthTrust Axiom LLC | 22,347 | $132,000 | 0.06% |
| SECTORAL ASSET MANAGEMENT INC | 100,000 | $594,000 | 0.05% |
| Virtu Financial LLC | 24,577 | $146,000 | 0.02% |
| PDT Partners, LLC | 61,839 | $367,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 26,039 | $155,000 | 0.02% |
| MGO ONE SEVEN LLC | 10,000 | $59,000 | 0.01% |
| WINTON GROUP Ltd | 45,208 | $269,000 | 0.01% |
| Ancora Advisors LLC | 36,350 | $216,000 | 0.01% |